Dr Susan O’Brien
When a doctor with a world-wide reputation in CLL gives a report, and then the report is commented upon by Dr Kanti Rai, then it is time to seriously listen or read.
This is information from real experts.
While the ‘ news ‘ is not truly new, it is laid out in simple terms that idelalisib will give a 97% response rate.
That is a truly amazing figure and fantastic news.
Read more at :- oncologypractice.com/oncolo...
Hopefully it will not be too long before these drugs are available. Certainly having the FDA put them on a ‘fast-track’ program is good news.